These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 6290925)

  • 21. beta-Adrenergic, CRF-ergic and dopaminergic mechanisms controlling alpha-MSH secretion in rat pars intermedia cells in primary culture.
    Meunier H; Labrie F
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):411-5. PubMed ID: 6298887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical identification of the beta-adrenoceptor and evidence for the involvement of an adenosine 3',5'-monophosphate system in the beta-adrenergically induced release of alph-melanocyte-stimulating hormone in the intermediate lobe of the rat pituitary gland.
    Cote T; Munemura M; Eskay RL; Kebabian JW
    Endocrinology; 1980 Jul; 107(1):108-16. PubMed ID: 6103799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of a D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland decreases the responsiveness of the beta-adrenoceptor: biochemical mechanism.
    Cote TE; Grewe CW; Kebabian JW
    Endocrinology; 1981 Feb; 108(2):420-6. PubMed ID: 6256151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release of alpha-melanocyte-stimulating hormone from dispersed cells of the intermediate lobe of the rat pituitary gland: involvement of catecholamines and adenosine 3',5'-monophosphate.
    Munemura M; Eskay RL; Kebabian JW
    Endocrinology; 1980 Jun; 106(6):1795-803. PubMed ID: 6245851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dopamine receptor in the intermediate lobe of the rat pituitary gland: pharmacological characterization.
    Munemura M; Cote TE; Tsuruta K; Eskay RL; Kebabian JW
    Endocrinology; 1980 Dec; 107(6):1676-83. PubMed ID: 6107242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [[Dopamine receptor; characterization of D-2 receptor in the intermediate lobe of the pituitary gland (author's transl)].
    Munemura M
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1600-8. PubMed ID: 6272362
    [No Abstract]   [Full Text] [Related]  

  • 27. The activity of substituted benzamides in biochemical models of dopamine receptors.
    Kebabian JW; Tsuruta K; Cote TE; Grewe CW
    Adv Biochem Psychopharmacol; 1982; 35():17-49. PubMed ID: 6293277
    [No Abstract]   [Full Text] [Related]  

  • 28. [D-2 dopamine receptor and hormone release in the intermediate lobe of the pituitary gland].
    Munemura M
    Tanpakushitsu Kakusan Koso; 1986 Feb; 31(2):116-31. PubMed ID: 3014608
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors.
    Lefkowitz RJ; Caron MG; Stiles GL
    N Engl J Med; 1984 Jun; 310(24):1570-9. PubMed ID: 6145093
    [No Abstract]   [Full Text] [Related]  

  • 30. Adrenergic receptors: molecular mechanisms of clinically relevant regulation.
    Lefkowitz RJ; Caron MG
    Clin Res; 1985 Sep; 33(3):395-406. PubMed ID: 2994939
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro study of beta-adrenergic receptors.
    Wolfe BB; Harden TK; Molinoff PB
    Annu Rev Pharmacol Toxicol; 1977; 17():575-604. PubMed ID: 17362
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple control of calcium channel gating by dopamine D2 receptors in frog pituitary melanotrophs.
    Valentijn JA; Vaudry H; Cazin L
    Ann N Y Acad Sci; 1993 May; 680():211-28. PubMed ID: 8390152
    [No Abstract]   [Full Text] [Related]  

  • 33. Catecholamine receptors.
    Levitzki A
    Rev Physiol Biochem Pharmacol; 1978; 82():1-26. PubMed ID: 28558
    [No Abstract]   [Full Text] [Related]  

  • 34. The antidepressant effect of beta-adrenoreceptor subsensitivity: a brief review and clinical implications.
    Manji H; Brown JH
    Can J Psychiatry; 1987 Dec; 32(9):788-97. PubMed ID: 2830004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular localization of responses to catecholamines in brain tissue.
    Stone EA; Bing G; John SM; Zhang Y; Filer D
    Prog Brain Res; 1992; 94():303-7. PubMed ID: 1337613
    [No Abstract]   [Full Text] [Related]  

  • 36. Catecholamines in critical care. The commonly used catecholamines: receptor and clinical profile, indications and dosages.
    Santman FW
    Pharm Weekbl Sci; 1992 Oct; 14(5):290-6. PubMed ID: 1437512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical assessment of adrenoceptor function and regulation: new directions and clinical relevance.
    Nahorski SR; Barnett DB
    Clin Sci (Lond); 1982 Aug; 63(2):97-105. PubMed ID: 6123400
    [No Abstract]   [Full Text] [Related]  

  • 38. Catecholamines and the splanchnic circulation.
    Russell JA
    Crit Care Med; 1999 Feb; 27(2):242-3. PubMed ID: 10075035
    [No Abstract]   [Full Text] [Related]  

  • 39. Biochemical and physiological studies of the beta-adrenoceptor and the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland: a review.
    Cote TE; Eskay RL; Frey EA; Grewe CW; Munemura M; Stoof JC; Tsuruta K; Kebabian JW
    Neuroendocrinology; 1982; 35(3):217-24. PubMed ID: 6290925
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.